Abbott Defends India IPR, Patent Handling Before Trade Group
This article was originally published in PharmAsia News
Executive Summary
Abbott Laboratories said in a filing with the U.S. International Trade Commission it has no problems with India's handling of intellectual property rights and patents, despite protests by several of its colleagues.